A PHARMACEUTICAL COMPOSITION HAVING ANTIPSYCHOTIC, ANTIDEPRESSANT OR ANTIEPILEPTIC ACTIVITY WITH REDUCED SIDE EFFECT
O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof (BGP-15) can be used for the prevention or reduction of weight gain or obesity in a patient treated with an antipsychotic drug or an antidepressant drug or an antiepileptic drug.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; por |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MIKE BROWNSTEIN KALMAN TAKACS JOZSEF MANDL KALMAN TORY JESSE ROTH GABOR BALOGH ATTILA KOLONICS ZOLTAN SZILVASSY BALAZS SUEMEGI LASZLO VIGH JANOS EGRI SANDOR BERNATH PETER LITERATI NAGY |
| description | O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof (BGP-15) can be used for the prevention or reduction of weight gain or obesity in a patient treated with an antipsychotic drug or an antidepressant drug or an antiepileptic drug. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PT2089032EE</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PT2089032EE</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PT2089032EE3</originalsourceid><addsrcrecordid>eNqNi8EKgkAURd20iOof3gcUiG5qOTyfzQN1hpmn4kokplWUoP9Pg_QBre69h3P3yarAauVqhdQKo6oATW2NZ2HTgFYdN3dQjbD1A2oTlfM2C7KOvI8VjNsIWa7IRgEUCncsA_QsGhwVLVIBPn6AypJQjsnuOb2WcPrlIYGSBPUlzJ8xLPP0CO-wjlay9HpL84wo_0P5Ao5tOSw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>A PHARMACEUTICAL COMPOSITION HAVING ANTIPSYCHOTIC, ANTIDEPRESSANT OR ANTIEPILEPTIC ACTIVITY WITH REDUCED SIDE EFFECT</title><source>esp@cenet</source><creator>MIKE BROWNSTEIN ; KALMAN TAKACS ; JOZSEF MANDL ; KALMAN TORY ; JESSE ROTH ; GABOR BALOGH ; ATTILA KOLONICS ; ZOLTAN SZILVASSY ; BALAZS SUEMEGI ; LASZLO VIGH ; JANOS EGRI ; SANDOR BERNATH ; PETER LITERATI NAGY</creator><creatorcontrib>MIKE BROWNSTEIN ; KALMAN TAKACS ; JOZSEF MANDL ; KALMAN TORY ; JESSE ROTH ; GABOR BALOGH ; ATTILA KOLONICS ; ZOLTAN SZILVASSY ; BALAZS SUEMEGI ; LASZLO VIGH ; JANOS EGRI ; SANDOR BERNATH ; PETER LITERATI NAGY</creatorcontrib><description>O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof (BGP-15) can be used for the prevention or reduction of weight gain or obesity in a patient treated with an antipsychotic drug or an antidepressant drug or an antiepileptic drug.</description><language>eng ; por</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110323&DB=EPODOC&CC=PT&NR=2089032E$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110323&DB=EPODOC&CC=PT&NR=2089032E$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MIKE BROWNSTEIN</creatorcontrib><creatorcontrib>KALMAN TAKACS</creatorcontrib><creatorcontrib>JOZSEF MANDL</creatorcontrib><creatorcontrib>KALMAN TORY</creatorcontrib><creatorcontrib>JESSE ROTH</creatorcontrib><creatorcontrib>GABOR BALOGH</creatorcontrib><creatorcontrib>ATTILA KOLONICS</creatorcontrib><creatorcontrib>ZOLTAN SZILVASSY</creatorcontrib><creatorcontrib>BALAZS SUEMEGI</creatorcontrib><creatorcontrib>LASZLO VIGH</creatorcontrib><creatorcontrib>JANOS EGRI</creatorcontrib><creatorcontrib>SANDOR BERNATH</creatorcontrib><creatorcontrib>PETER LITERATI NAGY</creatorcontrib><title>A PHARMACEUTICAL COMPOSITION HAVING ANTIPSYCHOTIC, ANTIDEPRESSANT OR ANTIEPILEPTIC ACTIVITY WITH REDUCED SIDE EFFECT</title><description>O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof (BGP-15) can be used for the prevention or reduction of weight gain or obesity in a patient treated with an antipsychotic drug or an antidepressant drug or an antiepileptic drug.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi8EKgkAURd20iOof3gcUiG5qOTyfzQN1hpmn4kokplWUoP9Pg_QBre69h3P3yarAauVqhdQKo6oATW2NZ2HTgFYdN3dQjbD1A2oTlfM2C7KOvI8VjNsIWa7IRgEUCncsA_QsGhwVLVIBPn6AypJQjsnuOb2WcPrlIYGSBPUlzJ8xLPP0CO-wjlay9HpL84wo_0P5Ao5tOSw</recordid><startdate>20110323</startdate><enddate>20110323</enddate><creator>MIKE BROWNSTEIN</creator><creator>KALMAN TAKACS</creator><creator>JOZSEF MANDL</creator><creator>KALMAN TORY</creator><creator>JESSE ROTH</creator><creator>GABOR BALOGH</creator><creator>ATTILA KOLONICS</creator><creator>ZOLTAN SZILVASSY</creator><creator>BALAZS SUEMEGI</creator><creator>LASZLO VIGH</creator><creator>JANOS EGRI</creator><creator>SANDOR BERNATH</creator><creator>PETER LITERATI NAGY</creator><scope>EVB</scope></search><sort><creationdate>20110323</creationdate><title>A PHARMACEUTICAL COMPOSITION HAVING ANTIPSYCHOTIC, ANTIDEPRESSANT OR ANTIEPILEPTIC ACTIVITY WITH REDUCED SIDE EFFECT</title><author>MIKE BROWNSTEIN ; KALMAN TAKACS ; JOZSEF MANDL ; KALMAN TORY ; JESSE ROTH ; GABOR BALOGH ; ATTILA KOLONICS ; ZOLTAN SZILVASSY ; BALAZS SUEMEGI ; LASZLO VIGH ; JANOS EGRI ; SANDOR BERNATH ; PETER LITERATI NAGY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PT2089032EE3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; por</language><creationdate>2011</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MIKE BROWNSTEIN</creatorcontrib><creatorcontrib>KALMAN TAKACS</creatorcontrib><creatorcontrib>JOZSEF MANDL</creatorcontrib><creatorcontrib>KALMAN TORY</creatorcontrib><creatorcontrib>JESSE ROTH</creatorcontrib><creatorcontrib>GABOR BALOGH</creatorcontrib><creatorcontrib>ATTILA KOLONICS</creatorcontrib><creatorcontrib>ZOLTAN SZILVASSY</creatorcontrib><creatorcontrib>BALAZS SUEMEGI</creatorcontrib><creatorcontrib>LASZLO VIGH</creatorcontrib><creatorcontrib>JANOS EGRI</creatorcontrib><creatorcontrib>SANDOR BERNATH</creatorcontrib><creatorcontrib>PETER LITERATI NAGY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MIKE BROWNSTEIN</au><au>KALMAN TAKACS</au><au>JOZSEF MANDL</au><au>KALMAN TORY</au><au>JESSE ROTH</au><au>GABOR BALOGH</au><au>ATTILA KOLONICS</au><au>ZOLTAN SZILVASSY</au><au>BALAZS SUEMEGI</au><au>LASZLO VIGH</au><au>JANOS EGRI</au><au>SANDOR BERNATH</au><au>PETER LITERATI NAGY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>A PHARMACEUTICAL COMPOSITION HAVING ANTIPSYCHOTIC, ANTIDEPRESSANT OR ANTIEPILEPTIC ACTIVITY WITH REDUCED SIDE EFFECT</title><date>2011-03-23</date><risdate>2011</risdate><abstract>O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof (BGP-15) can be used for the prevention or reduction of weight gain or obesity in a patient treated with an antipsychotic drug or an antidepressant drug or an antiepileptic drug.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; por |
| recordid | cdi_epo_espacenet_PT2089032EE |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | A PHARMACEUTICAL COMPOSITION HAVING ANTIPSYCHOTIC, ANTIDEPRESSANT OR ANTIEPILEPTIC ACTIVITY WITH REDUCED SIDE EFFECT |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T18%3A17%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MIKE%20BROWNSTEIN&rft.date=2011-03-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPT2089032EE%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |